πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7744934

Methods for modulating eicosanoid metabolism

The Board of Regents of the University of Texas System Β· Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7744931

Methods for treating oral cancers with herbal compositions

The Board of Regents of the University of Texas System Β· Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7737266

RNAi modulation of SCAP and therapeutics uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7732576

Tumor suppressor designated TS10Q23.3

The Board of Regents of the University of Texas System Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7732470

Compositions and methods for the treatment of renal and cardiovascular disease

The Board of Regents of the University of Texas System Β· Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7723104

Cancer specific promoters

The Board of Regents of the University of Texas System Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7718387

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using E

The Board of Regents of the University of Texas System Β· Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7718160

Radiolabeled compounds and liposomes and their method of making and using same

The Board of Regents of the University of Texas System Β· Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7714109

Combinations and kits for cancer treatment using selected antibodies to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7713934

Thrombin peptide derivatives

The Board of Regents of the University of Texas System Β· Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7709625

Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes fo

The Board of Regents of the University of Texas Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7709456

Modulation of gene expression by oligomers targeted to chromosomal DNA

The Board of Regents of the University of Texas System Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7709190

Influenza A virus vaccines and inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7704985

Treatment of irritable bowel syndrome and related bowel diseases

The Board of Regents of the University of Texas System Β· Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7704962

Small oligonucleotides with anti-tumor activity

The Board of Regents of the University of Texas System Β· Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7704497

Molecules with extended half-lives, compositions and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7700651

Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for th

The Board of Regents of the University of Texas System Β· Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7691567

Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators

The Board of Regents of the University of Texas System Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7691380

Combined methods for tumor coagulation and tumor treatment

The Board of Regents of the University of Texas System Β· Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7678386

Liposomes coated with selected antibodies that bind to aminophospholipids

The Board of Regents of the University of Texas Β· Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7670767

Genetic alterations associated with cancer

The Board of Regents of the University of Texas System Β· Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7670600

Molecules with extended half-lives, compositions and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7659306

Method of increasing gastric emptying

The Board of Regents of the University of Texas System Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7659071

Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, i

The Board of Regents of the University of Texas System Β· Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted